You just read:

Clementia Announces Top-line Results from Phase 2 Trial of Palovarotene for Treatment of Patients with Fibrodysplasia Ossificans Progressiva

News provided by

Clementia Pharmaceuticals Inc.

Oct 14, 2016, 14:05 ET